Comunicati stampa

Per tutte le richieste stampa, contattare: press@alivecor.com

July 23, 2024
Former Lions and Wales Rugby Captain Alun Wyn Jones partners with AliveCor to launch ‘Let’s Talk Rhythm’ campaign to raise awareness of atrial fibrillation
February 10, 2022
AliveCor Appoints Patricia Baran to Serve as Senior Vice President, Healthcare Americas
February 1, 2022
FDA Clears World’s First Credit-Card-Sized Personal ECG
January 11, 2022
AliveCor Announces Strategic Additions to Executive Team
January 7, 2022
Il NICE raccomanda il primo ECG basato su smartphone per il rilevamento della fibrillazione atriale (FA) per persone con sospetta FA parossistica tramite un monitoraggio qualità ambulatoriale

2021

December 20, 2021

AliveCor Lists its Industry-leading KardiaMobile 6L in Epic's App Orchard Marketplace

October 12, 2021

AliveCor Launches AliveCor Labs

September 1, 2021

KardiaMobile 6L is Superior to One Lead Personal Devices

July 27, 2021

New Study Demonstrates KardiaMobile 6L Reduces Urgent Healthcare Utilization

July 27, 2021

AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias

July 8, 2021

FDA Clears Personal ECG Device for Measurement of QTc Interval, a Critical Marker for Patient Safety

June 2, 2021

AliveCor Acquires CardioLabs and Sets the Stage for the Launch of Advanced Ambulatory Monitoring Services

May 26, 2021

Apple Abused Market Power in Cardio Device Market, Suit Alleges

May 21, 2021

ITC Formally Commences Investigation into Apple Watch Infringement of AliveCor Patents

April 20, 2021

AliveCor Files ITC Complaint Seeking to Bar U.S. Importation of Apple Watch

March 9, 2021

AliveCor Appoints Clyde Hosein as Chief Financial Officer

February 16, 2021

AliveCor Announces Collaboration with AstraZeneca to Develop Non-Invasive Potassium Monitoring Solutions

February 1, 2021

AliveCor Now Detects Six Times as Many Cardiac Conditions as Any Other Personal ECG

2020

November 23, 2020

FDA Clears First of its Kind Algorithm Suite for Personal ECG

November 16, 2020

AliveCor Closes $65 Million Financing to Accelerate Growth of Its Remote Cardiology Platform For Consumers, Employers, and Providers.

November 9, 2020

AliveCor Appoints Toby Cosgrove, M.D. to Board of Directors

September 24, 2020

AliveCor Brings World's Only Six-lead, FDA-cleared Personal ECG to India

July 9, 2020

AliveCor Expands Telemedicine Services to Support Heart Care at Home

May 6, 2020

AliveCor Partners with The Clifford Lab at Emory University and Georgia Institute of Technology

April 23, 2020

AliveCor and OMRON Announce Global Strategic Alliance for Comprehensive Remote Cardiovascular Monitoring

April 12, 2020

AliveCor to Provide QTc Measurement for Clinicians Treating COVID-19 Patients

March 23, 2020

New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients

February 19, 2020

AliveCor Receives Approval to Launch KardiaMobile in Mexico

2019

October 30, 2019

AliveCor and Huami Partner To Deliver The Next Generation of Medical Wearables

July 24, 2019

AliveCor Appoints Priya Abani as Chief Executive Officer; Elevates Vinod Khosla to Chairman of the Board

July 24, 2019

Olympic Icon Mark Spitz Partners with AliveCor To Build Awareness Around Heart Health

May 13, 2019

FDA Grants First Ever Clearance For Six-Lead Personal ECG Device

April 23, 2019

FDA Grants First-Ever Clearances to Detect Bradycardia and Tachycardia on a Personal ECG Device

April 19, 2019

New AliveCor Partnership Marks Expansion into Chinese Heart Health Market

March 18, 2019

Three New Studies Confirm Clinical Utility of AliveCor's KardiaMobile Device and AI Algorithms

February 26, 2019

AliveCor Appoints Dr. Jacqueline Shreibati, Chief Medical Officer

2018

November 12, 2018

AliveCor AI Found to Compare Favorably to Surgically Implanted Loop Recorder

November 12, 2018

AliveCor's Mobile ECG Technology Could Enable More Rapid Diagnosis and Treatment of Heart Attacks

September 10, 2018

FDA Designates AliveCor’s Bloodless Hyperkalemia Test a “Breakthrough Device.”

May 10, 2018

Previously Invisible Long QT Syndrome Now Observable With Machine Learning

April 5, 2018

AliveCor Data Yield Reaches 25MM ECGs

March 12, 2018

Cleveland Clinic Study Affirms Accurate Detection of Atrial Fibrillation by KardiaBand for Apple Watch

February 20, 2018

AliveCor Named No.1 Artificial Intelligence Company in Fast Company’s 2018 Most Innovative Companies Ranking

2017

December 12, 2017

AliveCor Granted Patent for Proactive Notification of Possible Heart Arrhythmias

November 30, 2017

FDA Clears First Medical Device Accessory for Apple Watch®

September 6, 2017

New Research Confirms Significance of AliveCor’s 30 Second EKG

July 19, 2017

AI That Sees the Invisible: AliveCor and Mayo Clinic Announce Collaboration to Develop Groundbreaking AI Technology to Help Prevent Sudden Cardiac Death

March 16, 2017

AliveCor Unveils First AI-Enabled Platform for Doctors to Improve Stroke Prevention Through Early Atrial Fibrillation Detection

February 13, 2017

AliveCor Named to Fast Company's Top 10 Most Innovative Companies in Health

AliveCor Inc., 189 N Bernardo Ave, Suite 100, Mountain View, California 94043

Comunicati stampa

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012